Data about transplants using unrelated marrow donors and umbilical cord blood units from the donor registry of the C.W. Bill Young Cell Transplantation Program (Program), including the National Cord Blood Inventory, are reported annually.
These data include the number of transplants performed along with the following information:
On this page:
Since the registry was established in 1987, it has facilitated more than 61,000 marrow and cord blood transplants for patients who do not have a matching donor in their family. In 2013, the registry facilitated nearly 6,300 transplants, an increase of almost 500 transplants over the previous year.
The blood cancers (hematologic malignancies) for which patients received an unrelated bone marrow or cord blood unit transplant most often during 2013 were:
The number of transplants continues to increase, with the largest areas of growth in AML, ALL, MDS and NHL.
In 2013, children (0 to 17 years) received 19 percent of transplants, adults 18 to 50 years received 36 percent of transplants, adults 51 to 64 years received 31 percent of transplants, and adults over age 65 received 14 percent of transplants.
For the last several years, transplants have increased steadily for patients of most races.
Since 2005, transplants for patients who reported their ethnicity as Hispanic or Latino has remained steady, often increasing.
During 2013, cord blood units were used in 1,102 transplants. The National Cord Blood Inventory provided 714 cord blood units for these transplants.
Also, 1,292 transplants were performed using bone marrow and more than 3,889 transplants used peripheral blood stem cells.
In 2013, cord blood was used to help 31 percent of patients from all races who received a transplant.
Nearly one third of patients who recorded their ethnicity as Hispanic or Latino received a cord blood transplant.
*Patients are asked to record both their race and ethnicity. Patients who indicated their ethnicity as Hispanic or Latino are also included in the race data.
Find more information about patient survival using marrow donors or donated cord blood units from the registry.